Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 11, 2024InflammopharmacologyOpen Access

Preclinical efficacy of oral and nasal rivastigmine-loaded chitosan nano-particles on AlCl3-induced Alzheimer’s-like disease in rats

View Full Paper
Ask AI
Bookmark
Share

Authors

DEDina E. ElMosbahMKMarwa S. KhattabMIMarwa A. Ibrahim

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

ElMosbah et al. (2024) studied this question.

synapsesocial.com/papers/68e5cb66b6db643587561cfdhttps://doi.org/10.1007/s10787-024-01541-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Formulation and characterization of polymeric nanoparticle of Rivastigmine for effective management of Alzheimer’s disease2024 · 26 citations
  2. 2Synthesis of a Rivastigmine and Insulin Combinational Mucoadhesive Nanoparticle for Intranasal Delivery2024 · 17 citations
  3. 3Taxifolin-Functionalized Rivastigmine Liposomal Nanoformulation: A Synergistic Approach for Alzheimer’s Disease Management2026
  4. 4Formulation of Rivastigmine-Loaded Nanolipid Mucoadhesive Gel Using <em>Moringa oleifera</em> Mucilage for Enhanced Mucosal Delivery in Alzheimer’s Disease2025
  5. 5The improvement potential of camel milk whey as a natural remedy in comparison with Rivastigmine chitosan-loaded nanoparticles in aluminum chloride induced Alzheimer-like disease in rats2024 · 4 citations